GSTM1 and sickle cell disease: Previous studies of aging and the elderly in sickle cell disease have shown that Hb may be expected to decrease over time.[17, 24–27] Our survivor population did show this expected decrease; indeed our mortality population suggest that the lack of this decrease might be a cause of concern in the long term follow-up of the individual patient.